- Home
- Equipment
- canada british columbia
- clinical trials research
Show results for
Refine by
Clinical Trials Research Equipment Supplied In Canada British Columbia
15 equipment items found
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of THC for anorexia and ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of CBD for treatment-resistant ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
We believe our cellular immunotherapy is most effective when the patient’s HLA-type matches the Bria-IMT™ HLA-type. We are engineering 15 unique HLA types (molecules) into Bria-IMT™, collectively referred to as Bria-OTS™, allowing for matching of over 99% of patients with advanced breast cancer. A simple saliva test is used to determine the HLA-type of each ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Citrullination is a highly relevant post-translational modification of proteins that occurs in RA and certain other conditions. In the extracellular space, 14-3-3η becomes citrullinated (cit) in the presence of peptidylarginine deiminases (PAD) enzymes and this extracellular modified form of the protein, cit-14-3-3η, also elicits an auto-immune response that generates cit-14-3-3η ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCH-01 is a proprietary autologous cell therapy being developed to treat pattern baldness.* *This product is currently in clinical testing and not yet commercially available. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. Though several cell types are involved, dermal sheath cup cells, located at base of ...
Manufactured by:Acuitas Therapeutics based inVancouver, BRITISH COLUMBIA (CANADA)
Proteins are the “workhorses” within cells responsible for metabolic processes, transport processes and structural elements. They are coded by genes on DNA and this code is transcribed into a message (messenger RNA or mRNA) within the cell nucleus. This mRNA then leaves the nucleus and is translated into the protein on ribosomes (Figure 1). Therapeutic mRNA is being developed as a new ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCT-01 is a proprietary autologous cell therapy being developed to treat chronically damaged tendons. * *This product is currently in clinical testing and not yet commercially available. RCT-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...
Manufactured by:Sepset Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Sepset is developing a blood test for hospitals to identify septic patients in the emergency room (ER) and predict those who will have high risk for organ ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique companies using safe therapeutic agents for diagnostic indication. As a non-invasive cost effective red alert tool, it is valuable to physicians around the ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureSelect Target Enrichment System is the most proven target enrichment solution today. This technology enables the capture of genomic targets using long 120nt RNA baits which allow for efficient enrichment of regions of interest facilitating confident variant calling. The SureSelectQXT Reagent Kit is a combined shearing-free transposase-based library prep and target enrichment solution that ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
Total Confidence qPCR delivering flexibility, precision, and performance. The AriaMx Real-Time PCR System is a fully integrated quantitative PCR amplification, detection, and data analysis system. The system design combines a state-of-the-art thermal cycler, an advanced optical system with an LED excitation source, and complete data analysis software. The instrument can hold up to six optics ...